Bill Text: IL HB3472 | 2019-2020 | 101st General Assembly | Introduced

---

Bill Title: Amends the Illinois Insurance Code. Provides that a group or individual policy of accident and health insurance shall provide coverage for the cost of opioid treatment drugs, including, but not limited to, opioid antagonists, regardless of whether or not they are generic drug formularies, and other buprenorphine-based medications meant to treat opioid addiction or prevent overdose by opioid use. Effective January 1, 2020.

Spectrum: Partisan Bill (Democrat 2-0)

Status: (Introduced - Dead) 2019-08-07 - Added Co-Sponsor Rep. Lindsey LaPointe [HB3472 Detail]

Download: Illinois-2019-HB3472-Introduced.html

---

101ST GENERAL ASSEMBLY State of Illinois 2019 and 2020 HB3472 Introduced , by Rep. Deb Conroy SYNOPSIS AS INTRODUCED:
215 ILCS 5/356z.33 new
Amends the Illinois Insurance Code. Provides that a group or individual policy of accident and health insurance shall provide coverage for the cost of opioid treatment drugs, including, but not limited to, opioid antagonists, regardless of whether or not they are generic drug formularies, and other buprenorphine-based medications meant to treat opioid addiction or prevent overdose by opioid use. Effective January 1, 2020.
LRB101 10553 SMS 55659 b
A BILL FOR
HB3472 LRB101 10553 SMS 55659 b
AN ACT concerning regulation.
Be it enacted by the People of the State of Illinois,
represented in the General Assembly:
Section 5. The Illinois Insurance Code is amended by adding
Section 356z.33 as follows:
(215 ILCS 5/356z.33 new)
Sec. 356z.33. Coverage for opioid addiction treatment
drugs.
(a) As used in this Section, "opioid antagonist" means a
drug that binds to opioid receptors and blocks or inhibits the
effect of opioids acting on those receptors, including, but not
limited to, naloxone hydrochloride or any other similarly
acting drug approved by the U.S. Food and Drug Administration.
(b) A group or individual policy of accident and health
insurance amended, delivered, issued, or renewed after the
effective date of this amendatory Act of the 101st General
Assembly shall provide coverage for the cost of opioid
treatment drugs, including, but not limited to, opioid
antagonists, regardless of whether or not they are generic drug
formularies, and other buprenorphine-based medications meant
to treat opioid addiction or prevent overdose by opioid use.
Section 99. Effective date. This Act takes effect January

HB3472 - 2 - LRB101 10553 SMS 55659 b
1, 2020.